Back
PLBY Group Vs. Kymera Therapeutics Industry Stock Comparison
Sell
25
PLBY
PLBY Group
Last Price:
0.61
Seasonality Move:
-20.55%
Buy
62
KYMR
Kymera Therapeutics
Last Price:
42.51
Seasonality Move:
-9.55%
Sell
25
PLBY Group (PLBY)
is a Sell
Is PLBY Group a Buy, Sell or Hold?
- The current PLBY Group [PLBY] share price is $0.71. The Score for PLBY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- PLBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $43.00. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PLBY Stock Price Chart
What is PLBY Group's stock price today?
-
The PLBY Group share price today is $0.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $43.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.
PLBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 43.45 | Sell |
Chaikin Money Flow: | 491244 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.72 - 0.88) | Sell |
Bollinger Bands (100): | (0.79 - 0.99) | Sell |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.04 | Buy |
Relative Strength Index (14 RSI): | 55.08 | Buy |
Chaikin Money Flow: | 127907 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.38 - 45.36) | Buy |
Bollinger Bands (100): | (32.42 - 41.32) | Buy |
PLBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.72 | Sell |
20-day SMA: | 0.8 | Sell |
50-day SMA: | 0.82 | Sell |
200-day SMA: | 0.89 | Sell |
8-day EMA: | 0.71 | Sell |
20-day EMA: | 0.77 | Sell |
50-day EMA: | 0.82 | Sell |
200-day EMA: | 1.07 | Sell |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.54 | Buy |
20-day SMA: | 43.04 | Sell |
50-day SMA: | 37.57 | Buy |
200-day SMA: | 32.59 | Buy |
8-day EMA: | 42.23 | Buy |
20-day EMA: | 41.74 | Buy |
50-day EMA: | 39.34 | Buy |
200-day EMA: | 33.93 | Buy |
PLBY Group Earnings Growth & PLBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and an increase next year of $0.20 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.33 per share.
PLBY Group Technical Analysis
Jul 31 | Aug 1 | Aug 2 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jul 31 | Aug 1 | Aug 2 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |